# Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?

> **NCT03267459** · — · RECRUITING · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 60 (estimated)

## Conditions studied

- Retinoblastoma

## Interventions

- **DEVICE:** Dynamic contrast-enhanced MRI

## Key facts

- **NCT ID:** NCT03267459
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-01-11
- **Primary completion:** 2028-01
- **Final completion:** 2030-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03267459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03267459, "Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03267459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*